4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000069
Director sold 1,500 shares at $34.02 ($51,030)
- Director acquired 1,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pande Atul Director | 2026-06-15 | Option exercise 10b5-1 | +1,500 | $8.43 | $12,645 | 118,231 | D |
| Pande Atul Director | 2026-06-15 | Sale 10b5-1 | −1,500 | $34.02 | $51,030 | 116,731 | D |
| Derivatives | |||||||
| Pande Atul Director | 2026-06-15 | Option exercise · Stock Option (right to buy) 10b5-1 | −1,500 | 69,681 | D | ||
| Open-market sales · 1,500 sh · avg $34.02 · $51,030 | |||||||
Loading xslF345X06/wk-form4_1781640191.xml…